Zoriel Pharmaceuticals LLP

Zoriel Pharmaceuticals LLP - chemicals in Assandh, Haryana, India. Directors, charges & compliance details.
LLPIN AAO-0043 Incorporated 11 January 2019 ROC Delhi HQ Assandh, Haryana, India
Active Limited Liability Partnership chemicals
Data last updated
Contribution obligation
₹50,000
As per LLP agreement
LLP age
7 yrs
Est. 2019
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
11 Jan 2019
Date of incorporation
Entity type
LLP
As registered with MCA

About Zoriel Pharmaceuticals LLP

Data last updated:

Zoriel Pharmaceuticals LLP is a limited liability partnership (LLP) based in Assandh, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 January 2019 and has been in existence for over 7 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAO-0043.

The LLP has a total obligation of contribution of β‚Ή50,000. It is led by designated partners Parvesh and Reeta Rani.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Assandh, Haryana.

Company details

LLPIN AAO-0043
Incorporation Date 11 January 2019
Total Obligation of Contribution β‚Ή50,000
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

Zoriel Pharmaceuticals LLP's registered office is in Assandh, Haryana.

  • Registered Address
    77 Munak, Karnal, Assandh, Haryana, India – 132040
  • Industry
    Chemicals, Manufacturing, Chemicals And Chemical Products
Comprehensive company report
Zoriel Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Zoriel Pharmaceuticals LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Zoriel Pharmaceuticals LLP, buy the company report.

Designated partners of Zoriel Pharmaceuticals LLP

Zoriel Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
ParveshDesignated Partner22 Apr 20197 Years 6 MonthsCurrent
Reeta RaniDesignated Partner11 Jan 20197 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Zoriel Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Zoriel Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Zoriel Pharmaceuticals LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Parvesh was appointed as Designated Partner on 22 Apr 2019.

AGM
Zoriel Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Zoriel Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Parvesh was appointed as Designated Partner.
Appointed
Reeta Rani was appointed as Designated Partner.
Incorporation
11 Jan 2019
Zoriel Pharmaceuticals Llp was registered on 11 Jan 2019 with Roc Delhi & aged 7 years 9 months as per MCA records.

Frequently asked questions

Zoriel Pharmaceuticals is an active limited liability partnership based in Assandh, Haryana, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 11 January 2019 (7+ years old) and is registered under LLPIN AAO-0043.

Zoriel Pharmaceuticals has 2 current designated partners:

The latest financial statements of Zoriel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Zoriel Pharmaceuticals is AAO-0043. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Zoriel Pharmaceuticals was incorporated on 11 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

Parvesh was appointed as Designated Partner on 22 Apr 2019. Reeta Rani was appointed as Designated Partner on 11 Jan 2019.

The registered office of Zoriel Pharmaceuticals is at 77 Munak, Karnal, Assandh, Haryana, India – 132040.

Zoriel Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Zoriel Pharmaceuticals can be reached at its registered office: 77 Munak, Karnal, Assandh, Haryana, India – 132040.

Zoriel Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.